Results 101 to 110 of about 1,054 (155)

Migraine-induced cochlear injury triggers ZBP1-mediated PANoptosis via CGRP signaling. [PDF]

J Headache Pain
Xu W, Zhai N, Chen J, Zhou S, Tian E, Guo Z, Zhou Z, Yu X, Zhai Z, Zhang X, Wang Y, Ma X, Lu Y, Zhang S.   +13 more
europepmc   +1 more source

Retrospective Review of Dual CGRP-Targeted Regimens for Acute and Preventive Treatment of Migraines in a Veteran Population. [PDF]

Fed Pract
Forrest A, Billow D, Martin A.
europepmc   +1 more source

Investigation of the rimegepant effect on cerebral and extracerebral arteries during migraine attacks: a longitudinal magnetic resonance angiography study. [PDF]

Brain Commun
Chaudhry BA, Younis S, Al-Mashat H, Gozalov E, Amin TM, de Koning PJH, Larsson HBW, Amin FM.   +7 more
europepmc   +1 more source

Sensory neuron-derived CCL5 orchestrates an immunosuppressive niche via regulatory T cells to fuel head and neck tumor progression. [PDF]

J Immunother Cancer
Wu K, Zhang Z, Qin X, Feng G, Li H, Guo R, Hu Y, Ji Y, Wang Y, Yan M, Zhang C.   +10 more
europepmc   +1 more source

A Phase 1, Randomized, Placebo-Controlled, Multiple-Dose, Double-Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals. [PDF]

Clin Pharmacol Drug Dev
Bhardwaj R, Lim CN, Li Y, Matschke KT, Bertz R, Croop R, Liu J.   +6 more
europepmc   +1 more source

Safety and Effectiveness of Pain Medications for Migraine Management During Pregnancy and Lactation. [PDF]

Paediatr Drugs
Smirnoff L, Mancera NG, Hyppolite T, Lozano D, Cocores A.   +4 more
europepmc   +1 more source

A phase 1, multicenter, open-label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine. [PDF]

Headache
Lim CN, Mo G, Bhardwaj R, Comisar CM, Emerson BL, Matschke KT, Fisniku O, Bertz R, Croop R, Liu J.   +9 more
europepmc   +1 more source

Emerging pharmacological targets in migraine therapy: CGRP and beyond. [PDF]

Front Pharmacol
Atraszkiewicz D, Dahiya D.
europepmc   +1 more source

The use of triptans, opioids, and other rescue medications among patients with migraine prescribed calcitonin gene-related peptide inhibitors for migraine prophylaxis. [PDF]

J Manag Care Spec Pharm
Nguyen JL, Lee T, Swart ECS, Peasah SK, Ineh A, Patel U, Good CB.   +6 more
europepmc   +1 more source